Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Silankang (Combined Bifidobacterium, Lactobacillus, Enterococcus and Bacillus cereus) for pregnancy constipation
CTR20230469Phase 2Active
- Sponsor
- Hangzhou Grand Biologic Pharmaceutical Inc.
- Start
- Apr 2023
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of Silankang in functional constipation (FC), constipation, sponsored by Hangzhou Grand Biologic Pharmaceutical Inc.. Started Apr 2023; status: active.
02
Drugs
Silankang
03
Conditions
functional constipation (FC)constipation
Beyond the preview
Go deeper on CTR20230469.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20230469.